Multiple myeloma long-term survivors display sustained immune alterations decades after first line therapy https://www.biorxiv.org/content/10.1101/2023.05.27.542555v1?med=mas
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.